SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹18,194 Cr |
| Mar2024 | ₹16,984 Cr |
| Mar2023 | ₹19,906 Cr |
| Mar2022 | ₹17,208 Cr |
| Mar2021 | ₹16,146 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18,194 Cr | 7.13 | |
| Mar2024 | ₹16,984 Cr | -14.68 | |
| Mar2023 | ₹19,906 Cr | 15.68 | |
| Mar2022 | ₹17,208 Cr | 6.58 | |
| Mar2021 | ₹16,146 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,022.3 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
| MANKIND PHARMA | ₹92,784.1 Cr | 9.9% | 5.8% | -2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% |
9% |
8.6% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses